355 followers
RT @ASCO_pubs: Children’s Oncology Group ARST0332 Study: a risk based treatment strategy with lower XRT doses yielded improved outcomes in…
RT @ASCO_pubs: Children’s Oncology Group ARST0332 Study: a risk based treatment strategy with lower XRT doses yielded improved outcomes in…
RT @ASCO_pubs: Children’s Oncology Group ARST0332 Study: a risk based treatment strategy with lower XRT doses yielded improved outcomes in…
RT @ASCO_pubs: Children’s Oncology Group ARST0332 Study: a risk based treatment strategy with lower XRT doses yielded improved outcomes in…
Children’s Oncology Group ARST0332 Study: a risk based treatment strategy with lower XRT doses yielded improved outcomes in synovial sarcoma in children, adolescents, & young adults 👉https://t.co/1XtYDLqCl5 #CancerResearch @WCRD24Sept @ustunezer @lo…